A congressional committee takes up marijuana legalization, Pennsylvania's governor signs a fentanyl test strip bill into law, and more.

[image:1 align:left caption:true]Marijuana Policy

Congressional Committee Holds Hearing on Marijuana Legalization. The House Oversight Subcommittee on Civil Rights and Civil Liberties held a hearing Tuesday on marijuana legalization. Led by Chairman Jamie Raskin (D-MD), the committee examined "Developments in State Cannabis Laws and Bipartisan Cannabis Reforms at the Federal Level," using a joint memo published last Friday to lay out the main points of discussion.

Witnesses included Woodfin (Mayor of Birmingham, Alabama), Paul Armentano (Deputy Director of NORML), Andrew Freedman (Executive Director of Coalition for Cannabis Policy, Education, and Regulation [CPEAR]), Eric Goepel (Founder and CEO of Veterans Cannabis Coalition), Keeda Haynes (Senior Legal Advisor of Free Hearts), Amber Littlejohn (Policy Advisor of Global Alliance for Cannabis Commerce), and Jillian Snider (Policy Director of Criminal Justice & Civil Liberties). Among topics covered were the failed war on drugs, the need for state-level action to accompany President Biden's marijuana pardon announcement, veterans' access to medical marijuana, and hemp's potential as a building material. No votes were taken.

Medical Marijuana

Kentucky Governor Signs Executive Order Allowing Some Residents to Use Medical Marijuana. Gov. Andy Beshear (D) on Tuesday signed an executive order allowing patients who meet certain requirements to use and possess medical marijuana. Those eligible must suffer from one of 21 specified medical conditions. The medicine must be purchased in a state where it is legal (and keep your receipt!) and will be limited to eight ounces. Patients must get a letter from a physician certifying that they suffer from one of the specified conditions. The plan goes into effect on January 1.

Harm Reduction

AMA Reiterates Call for Harm Reduction Measures to Attack Overdose Problem. At its annual interim meeting this month, the American Medical Association passed a resolution encouraging the use of harm reduction practices to reduce overdose deaths in the county. The resolution called on city and state medical societies to advocate for harm reduction policies that create immunity for "drug paraphernalia" used in harm reduction, such as fentanyl test strips. "Fentanyl test strips are a point-of-care test that identifies fentanyl contamination in a drug supply with a specificity of 87.5% and a sensitivity of 95.2%," the resolution notes, but also notes that "possession of fentanyl test strips is explicitly legal in only 22 states."

But it is not just fentanyl test strips that the AMA wants to see: "The AMA has strongly supported increased use of a broad array of harm-reduction efforts to reduce death and other harms from nonmedical use of drugs, including for people who inject drugs," the group said. "These efforts include greater access to naloxone, syringe services programs and pilot programs for overdose prevention sites/supervised injection-use facilities. Fentanyl strips are part of this effort, and we urge states to take steps to help a vulnerable population."

Pennsylvania Governor Signs Fentanyl Test Strip Legislation in Bid to Reduce Overdoses. Gov. Tom Wolf (D) held a ceremonial signing Wedmesday for a new law (Act 111) that legalizes the use of fentanyl test strips and other forms of drug checking to prevent overdose deaths. The legislation passed the state House and Senate unanimously before going to the Governor's desk. The most recent data show Pennsylvania had the third highest number of overdose deaths of any state in the country for the 12-month period ending May 2022. Fentanyl test strips allow people who use drugs to easily test the drugs for the presence of fentanyl.